4.6 Article

Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index

Related references

Note: Only part of the references are listed.
Letter Cardiac & Cardiovascular Systems

Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes

Gjin Ndrepepa et al.

CLINICAL RESEARCH IN CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial

Kazuma Oyama et al.

Summary: The study investigated the associations between obesity, cardiorenal events, and the benefits of dapagliflozin in patients with type 2 diabetes mellitus. The results showed that higher BMI was associated with a higher risk of heart failure and atrial fibrillation. Dapagliflozin reduced body weight consistently across BMI categories, and obese patients tended to derive greater absolute risk reduction in heart failure and atrial fibrillation.

EUROPEAN HEART JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

Tomasz J. Guzik et al.

Summary: The dual-pathway antithrombotic therapy in the COMPASS trial showed consistent effects regardless of patient BMI or body weight, indicating no need for dose adjustments within the range of weights and BMI of patients enrolled. Further research should address this issue in relation to greater extremes of body weight.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Medicine, General & Internal

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials

Marco Valgimigli et al.

Summary: The study assessed the risks and benefits of P2Y(12) inhibitor monotherapy compared with dual antiplatelet therapy, finding that P2Y(12) inhibitor monotherapy was associated with lower risk of primary ischemic endpoints and lower bleeding risk compared to DAPT.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel The ABCD-GENE Score

Dominick J. Angiolillo et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2020)

Article Cardiac & Cardiovascular Systems

Ticagrelor With or Without Aspirin After Complex Percutaneous Coronary Intervention

George Dangas et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Medicine, General & Internal

Ticagrelor with or without Aspirin in High-Risk Patients after PCI

R. Mehran et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis

Bianca Rocca et al.

EUROPEAN HEART JOURNAL (2018)

Article Pharmacology & Pharmacy

Exposure-Response Analyses Supporting Ticagrelor Dosing Recommendation in Patients With Prior Myocardial Infarction

Daniel Roshammar et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2017)

Article Pharmacology & Pharmacy

Population pharmacokinetics of ticagrelor and AR-C124910XX in patients with prior myocardial infarction

Daniel Roshammar et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2017)

Review Cardiac & Cardiovascular Systems

The molecular mechanisms of obesity paradox

Alexios S. Antonopoulos et al.

CARDIOVASCULAR RESEARCH (2017)

Review Cardiac & Cardiovascular Systems

New insights into the role of adipose tissue in thrombosis

Gemma Vilahur et al.

CARDIOVASCULAR RESEARCH (2017)

Article Cardiac & Cardiovascular Systems

Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease

William Herrington et al.

CIRCULATION RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

Obesity and Cardiovascular Disease

Francisco B. Ortega et al.

CIRCULATION RESEARCH (2016)

Article Clinical Neurology

Risk Factors Assessed in Adolescence and the Later Risk of Stroke in Men: A 33-Year Follow-Up Study

Gabriel Hogstrom et al.

CEREBROVASCULAR DISEASES (2015)

Article Cardiac & Cardiovascular Systems

Platelet reactivity during ticagrelor maintenance therapy: A patient-level data meta-analysis

Dimitrios Alexopoulos et al.

AMERICAN HEART JOURNAL (2014)

Review Hematology

Inflammation, obesity, and thrombosis

Fahumiya Samad et al.

BLOOD (2013)

Review Cardiac & Cardiovascular Systems

Third universal definition of myocardial infarction

Kristian Thygesen et al.

EUROPEAN HEART JOURNAL (2012)

Article Cardiac & Cardiovascular Systems

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients

David Erlinge et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Article Clinical Neurology

Body Mass Index and Risk of Stroke among Chinese Men and Women

Lydia A. Bazzano et al.

ANNALS OF NEUROLOGY (2010)

Article Cardiac & Cardiovascular Systems

Body Mass Index and Risk of Stroke and Myocardial Infarction in a Relatively Lean Population Meta-Analysis of 16 Japanese Cohorts Using Individual Data

Hiroshi Yatsuya et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)

Letter Hematology

The role of weight and enteric coating on aspirin response in cardiovascular patients

A. Peace et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

Editorial Material Cardiac & Cardiovascular Systems

Body fat and cardiovascular risk: understanding the obesity paradox

Felicita Andreotti et al.

EUROPEAN HEART JOURNAL (2009)

Article Cardiac & Cardiovascular Systems

Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss

Carl J. Lavie et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Article Medicine, General & Internal

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Lars Wallentin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Cardiac & Cardiovascular Systems

Clinical end points in coronary stent trials - A case for standardized definitions

Donald E. Cutlip et al.

CIRCULATION (2007)